Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-10 Sale |
2023-11-14 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
4,764,008 | $0.2942 | $1,401,571 | 7,245,984 (Indirect) |
View |
| 2023-04-26 Purchase |
2023-04-28 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
50,999 | $0.74294 | $37,889 | 399,417 (Direct) |
View |
| 2023-03-09 Purchase |
2023-03-13 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
174,508 | $1.38 | $240,821 | 11,570,492 (Indirect) |
View |
| 2023-02-28 Purchase |
2023-03-02 06:24 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
5,000 | $1.52 | $7,600 | 344,918 (Direct) |
View |
| 2023-01-18 Purchase |
2023-01-19 06:05 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
6,800 | $1.62 | $11,016 | 339,918 (Direct) |
View |
| 2022-12-21 Sale |
2023-01-19 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | LARUE WILLIAM R Director |
120 | $1.2553 | $151 | 7,763 (Direct) |
View |
| 2022-12-29 Purchase |
2023-01-03 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | Brown Scott B. Chief Financial Officer |
3,500 | $1.49 | $5,215 | 21,628 (Direct) |
View |
| 2022-12-14 Purchase |
2022-12-16 5:03 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
167,500 | $1.253 | $209,877 | 5,671,585 (Indirect) |
View |
| 2022-12-14 Purchase |
2022-12-15 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
23,000 | $1.2937 | $29,755 | 333,118 (Direct) |
View |
| 2022-12-06 Sale |
2022-12-08 6:49 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
1,539 | $1.44 | $2,216 | 13,366,585 (Indirect) |
View |
| 2022-11-18 Purchase |
2022-11-22 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
13,900 | $1.41 | $19,599 | 310,118 (Direct) |
View |
| 2022-11-03 Purchase |
2022-11-04 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
9,200 | $1.52 | $13,984 | 296,218 (Direct) |
View |
| 2022-11-02 Purchase |
2022-11-03 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
6,000 | $1.59 | $9,540 | 287,018 (Direct) |
View |
| 2022-10-18 Purchase |
2022-10-19 7:22 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
12,500 | $1.65 | $20,625 | 9,578,124 (Indirect) |
View |
| 2022-10-07 Purchase |
2022-10-11 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
5,000 | $1.77 | $8,850 | 277,518 (Direct) |
View |
| 2022-10-03 Purchase |
2022-10-05 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
5,000 | $1.67 | $8,350 | 272,518 (Direct) |
View |
| 2022-09-29 Purchase |
2022-10-03 4:06 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
9,400 | $1.7415 | $16,370 | 5,863,124 (Indirect) |
View |
| 2022-09-27 Purchase |
2022-09-28 6:00 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
1,700 | $1.6924 | $2,877 | 5,853,724 (Indirect) |
View |
| 2022-09-22 Purchase |
2022-09-26 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
5,000 | $1.76 | $8,800 | 267,518 (Direct) |
View |
| 2022-09-22 Purchase |
2022-09-22 6:09 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
17,311 | $1.7297 | $29,943 | 5,852,024 (Indirect) |
View |
| 2022-09-20 Purchase |
2022-09-20 5:37 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
10,000 | $1.8524 | $18,524 | 5,838,124 (Indirect) |
View |
| 2022-09-19 Purchase |
2022-09-19 7:00 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
5,000 | $1.8733 | $9,367 | 5,828,124 (Indirect) |
View |
| 2022-09-12 Purchase |
2022-09-14 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Brown Scott B. Chief Financial Officer |
2,500 | $2.015 | $5,038 | 14,628 (Direct) |
View |
| 2022-07-26 Purchase |
2022-07-26 5:25 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
2,254 | $1.72 | $3,877 | 5,823,124 (Indirect) |
View |
| 2022-07-22 Purchase |
2022-07-25 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
4,500 | $1.85 | $8,325 | 262,518 (Direct) |
View |
| 2022-07-15 Purchase |
2022-07-15 6:06 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
11,826 | $1.7815 | $21,068 | 5,820,870 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-04-20 Option Award |
2024-03-13 5:59 pm |
N/A N/A |
Tracon Pharmaceuticals Inc. | TCON | Brown Scott B. CHIEF FINANCIAL OFFICER |
3,500 | $0.1377 | 249,928 (Direct) |
View |
| 2024-03-12 Option Award |
2024-03-13 5:59 pm |
N/A 2034-03-11 |
Tracon Pharmaceuticals Inc. | TCON | Brown Scott B. CHIEF FINANCIAL OFFICER |
224,800 | $0 | 249,928 (Direct) |
View |
| 2023-04-20 Option Award |
2024-03-13 5:56 pm |
N/A N/A |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES PRESIDENT AND CEO |
3,500 | $0.1377 | 924,717 (Direct) |
View |
| 2024-03-12 Option Award |
2024-03-13 5:56 pm |
N/A 2034-03-11 |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES PRESIDENT AND CEO |
518,300 | $0 | 924,717 (Direct) |
View |
| 2023-10-20 Option Award |
2024-03-13 5:56 pm |
N/A N/A |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES PRESIDENT AND CEO |
3,500 | $0.1333 | 924,717 (Direct) |
View |
| 2023-04-19 Option Award |
2023-04-21 8:55 pm |
N/A 2033-04-18 |
Tracon Pharmaceuticals Inc. | TCON | Johnson-Pratt Lisa Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2023-04-19 Option Award |
2023-04-21 8:52 pm |
N/A 2033-04-18 |
Tracon Pharmaceuticals Inc. | TCON | Lam Carol C. Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2023-04-19 Option Award |
2023-04-21 8:48 pm |
N/A 2033-04-18 |
Tracon Pharmaceuticals Inc. | TCON | PELLETIER SAUNDRA L Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2023-04-19 Option Award |
2023-04-21 8:44 pm |
N/A 2033-04-18 |
Tracon Pharmaceuticals Inc. | TCON | MATTINGLY MARTIN A Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2023-04-19 Option Award |
2023-04-21 8:41 pm |
N/A 2033-04-18 |
Tracon Pharmaceuticals Inc. | TCON | WORLAND STEPHEN T Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2023-04-19 Option Award |
2023-04-21 8:37 pm |
N/A 2033-04-18 |
Tracon Pharmaceuticals Inc. | TCON | LARUE WILLIAM R Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2023-04-19 Option Award |
2023-04-21 8:36 pm |
N/A 2033-04-18 |
Tracon Pharmaceuticals Inc. | TCON | Twiford J Rainer Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-09 9:31 pm |
N/A 2033-01-31 |
Tracon Pharmaceuticals Inc. | TCON | Adams Bonne J. Chief Operating Officer |
99,000 | $0 | 99,000 (Direct) |
View |
Ownership |
2023-02-09 9:26 pm |
N/A N/A |
Tracon Pharmaceuticals Inc. | TCON | Adams Bonne J. Chief Operating Officer |
0 | $0 | 190,547 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 7:58 pm |
N/A 2033-01-31 |
Tracon Pharmaceuticals Inc. | TCON | Brown Scott B. Chief Financial Officer |
144,000 | $0 | 144,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 7:55 pm |
N/A 2033-01-31 |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
332,000 | $0 | 332,000 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-08 6:49 pm |
2020-08-27 2030-08-27 |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
221,539 | $0.01 | 13,366,585 (Indirect) |
View |